These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 34934470)

  • 21. Clinical experience of a chronic urticaria referral university center.
    Andrade Coelho Dias G; Cunha Coelho F; Filippo P; Lacerda Pedrazzi D; Nogueira Arraes AC; Perelló MI; Chigres Kuschnir F; Costa E
    Eur Ann Allergy Clin Immunol; 2020 May; 52(3):112-120. PubMed ID: 31287262
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series.
    Ari A; Levy Y; Segal N; Maoz-Segal R; Benor S; Broides A; Horev A; Epstein-Rigbi N; Agmon-Levin N; Marcus N
    Pediatr Dermatol; 2020 Nov; 37(6):1051-1054. PubMed ID: 32951239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omalizumab in Chronic Urticaria: An Italian Survey.
    Damiani G; Diani M; Conic RRZ; Colli L; Ferrucci S; Martina E; Offidani AM; Pigatto PDM
    Int Arch Allergy Immunol; 2019; 178(1):45-49. PubMed ID: 30396176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.
    Giménez-Arnau AM
    Expert Opin Biol Ther; 2017 Mar; 17(3):375-385. PubMed ID: 28125304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
    Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
    Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Strategy According to Differences in Response to Omalizumab in Patients With Chronic Spontaneous Urticaria.
    Giménez Arnau AM; Valero Santiago A; Bartra Tomás J; Jáuregui Presa I; Labrador Horrillo M; Miquel Miquel FJ; Ortiz de Frutos J; Sastre J; Silvestre Salvador JF; Ferrer Puga M
    J Investig Allergol Clin Immunol; 2019; 29(5):338-348. PubMed ID: 30222111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.
    He L; Yi W; Huang X; Long H; Lu Q
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):424-448. PubMed ID: 34529248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management problems in severe chronic inducible urticaria: Two case reports.
    Bumbăcea RS; Deaconu CG; Berghea EC
    Exp Ther Med; 2019 Aug; 18(2):960-963. PubMed ID: 31384330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
    Ayse Ornek S; Orcen C; Church MK; Kocaturk E
    Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
    Hon KL; Li JTS; Leung AKC; Lee VWY
    Expert Opin Pharmacother; 2021 Mar; 22(4):497-509. PubMed ID: 32990110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term management of chronic spontaneous urticaria with omalizumab.
    Pinto Gouveia M; Gameiro A; Pinho A; Gonçalo M
    Clin Exp Dermatol; 2017 Oct; 42(7):735-742. PubMed ID: 28649751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The global burden of chronic urticaria for the patient and society.
    Gonçalo M; Gimenéz-Arnau A; Al-Ahmad M; Ben-Shoshan M; Bernstein JA; Ensina LF; Fomina D; Galvàn CA; Godse K; Grattan C; Hide M; Katelaris CH; Khoshkhui M; Kocatürk E; Kulthanan K; Medina I; Nasr I; Peter J; Staubach P; Wang L; Weller K; Maurer M
    Br J Dermatol; 2021 Feb; 184(2):226-236. PubMed ID: 32956489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
    Metz M; Ohanyan T; Church MK; Maurer M
    J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines.
    Chang J; Cattelan L; Ben-Shoshan M; Le M; Netchiporouk E
    J Asthma Allergy; 2021; 14():187-199. PubMed ID: 33727832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience of a specialized urticaria outpatient clinic from a Portuguese UCARE.
    Esteves Caldeira L; Paulino M; Coutinho C; Neto M; Pereira Barbosa M; Costa C
    Eur Ann Allergy Clin Immunol; 2023 Jan; 55(1):9-18. PubMed ID: 33949172
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
    Ghazanfar MN; Holm JG; Thomsen SF
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urticaria and Angioedema: an Update on Classification and Pathogenesis.
    Radonjic-Hoesli S; Hofmeier KS; Micaletto S; Schmid-Grendelmeier P; Bircher A; Simon D
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):88-101. PubMed ID: 28748365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric chronic spontaneous urticaria: a brief clinician's guide.
    Votto M; Achilli G; De Filippo M; Licari A; Marseglia A; Moiraghi A; Di Sabatino A; Marseglia GL
    Expert Rev Clin Immunol; 2022 Sep; 18(9):889-899. PubMed ID: 35833360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
    Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
    World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.
    Casale TB; Gimenez-Arnau AM; Bernstein JA; Holden M; Zuberbier T; Maurer M
    Dermatol Ther (Heidelb); 2023 Nov; 13(11):2573-2588. PubMed ID: 37776480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.